Grant Accelerator
Grant Accelerator Opportunities
Profile of Candidates
Leaders with specialized knowledge across priority healthcare sub-sector who enable targeted investment strategies and allow us to identify opportunities with precision
We seek leaders who think like entrepreneurs, embracing innovation and agility, resulting in a hands-on approach that fosters a culture of growth, adaptability, and long-term success
Acceleration Partners have led across critical business functions, allowing them to navigate complex challenges and implement impactful solutions
Acceleration Partners
As President and Chief Executive Officer of Kantar US, a life science market research and data analytics consultancy, Jerry led the company through a period of transformative growth and strategic evolution from 2017 to 2021. Under his leadership, Kantar was acquired by Bain Capital in 2019 and later divested its health division to Cerner in 2021. Jerry’s tenure was defined by data-driven decision-making, deep industry partnerships, and a focus on scaling high-value insights services across global healthcare markets.
Jerry was the founder of The Mattson Jack Group, a health insights and consulting firm established in 2000 and acquired by Kantar in 2003. He held successive executive roles at Kantar, including President, COO, and ultimately CEO, helping to shape its global healthcare and life sciences strategy.
Before founding Mattson Jack, Jerry held commercial leadership roles at Aventis (now Sanofi), where he developed a strong foundation in pharmaceutical strategy and market access. His career reflects along-standing commitment to advancing healthcare commercialization, integrating science and data with actionable insight.
Jerry brings a unique blend of entrepreneurial experience, operational excellence, and commercial acumen to every organization he leads.
As President of the Contract Development and Manufacturing Operation (“CDMO”) Drug Substance division at Cambrex, Dave Meadows held full P&L responsibility and led significant growth across the custom Active Pharmaceutical Ingredient (“API”) business. He oversaw all key functions including business development, commercial operations, R&D, program management, and manufacturing. Prior to Cambrex, Dave served as President of the Scientific and Regulatory Review Group at WCG Clinical, where he successfully led the turnaround of six operating companies.
At both organizations, Dave drove measurable improvements in operational performance, resulting in sustained organic revenue and EBITDA growth. He also played a key role in strategic M&A initiatives, leading due diligence efforts and overseeing the successful integration of acquired businesses.
Dave is a highly analytical and results-oriented leader with a passion for operational excellence. He specializes in business transformation and turnaround strategies, leveraging data-driven decision-making, and focuses on key performance metrics to build high-performing, execution-focused teams.
As President and Chief Executive Officer of Midwest Medical and its affiliates, a leading medical transportation business serving hospitals across multiple states, Jeff directed the strategic growth of the organization. His experience includes all aspects of patient care, compliance, operations, risk management, business development, and finance. He believes in data driven growth and facilitating true partnerships with customers through transparency and collaboration.
Working with his leadership team, he developed sustainable, tailored solutions for a wide range of market profiles, from super rural to large, inner-city urban communities.
Jeff has experience applying creative methods to enhance medical transportation operations and help them realize their opportunities for growth and quality operations. He has a strong commitment to improving the industry and has been involved with a variety of related industry organizations throughout his career.